Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Daxor Corporation Common Stock (DXR)

Surgical & Medical Instruments & Apparatus

https://www.daxor.com

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

350 FIFTH AVENUE, SUITE 7120
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/17/1992

Market Cap

43,532,370

Shares Outstanding

4,740,000

Weighted SO

4,792,319

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

INFU --.--%

MHUA --.--%

KRMD --.--%

LMAT --.--%

POCI --.--%

UTMD --.--%

MLSS --.--%

PDEX --.--%

Beta

-0.5340

Last Div

0.0000

Range

7.11-10.04

Chg

0.2900

Avg Vol

1317

Mkt Cap

43532370

Exch

NASDAQ

Country

US

Phone

12123308500

DCF Diff

7.5068

DCF

0.9932

Div Yield

0.0000

P/S

1.2555

EV Multiple

41.4417

P/FV

1.2719

Div Yield %

0.0000

P/E

4.5970

PEG

0.1696

Payout

0.0000

Current Ratio

0.2510

Quick Ratio

0.2510

Cash Ratio

0.0000

DSO

0.1495

DIO

0.0000

Op Cycle

0.1495

DPO

86.5720

CCC

-86.4226

Gross Margin

0.9875

Op Margin

-0.0033

Pretax Margin

0.0040

Net Margin

0.2714

Eff Tax Rate

3.8080

ROA

0.2699

ROE

0.2924

ROCE

-0.0033

NI/EBT

67.0606

EBT/EBIT

-1.2376

EBIT/Rev

-0.0033

Debt Ratio

0.0217

D/E

0.0222

LT Debt/Cap

0.0217

Total Debt/Cap

0.0217

Int Coverage

-2.3091

CF/Debt

-10.8895

Equity Multi

1.0252

Rec Turnover

2442.0321

Pay Turnover

4.2161

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.9943

OCF/Share

-1.7121

FCF/Share

-1.7121

Cash/Share

0.0000

OCF/Sales

-0.2373

FCF/OCF

1.0000

CF Coverage

-10.8895

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.2719

P/B

1.2719

P/S

1.2555

P/E

4.5970

P/FCF

-5.2903

P/OCF

-5.2568

P/CF

-5.2568

PEG

0.1696

P/S

1.2555

EV Multiple

41.4417

P/FV

1.2719

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 02, 08:30 Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.03 01/05/2018 12/21/2017 01/08/2018 01/12/2018
0.03 12/20/2016 11/21/2016 12/22/2016 12/29/2016
0.04 12/18/2015 12/11/2015 12/22/2015 12/29/2015
0.03 12/04/2014 11/17/2014 12/08/2014 12/26/2014
0.05 12/05/2013 11/15/2013 12/09/2013 12/27/2013
0.10 12/07/2012 11/29/2012 12/11/2012 12/27/2012
0.10 08/10/2012 08/03/2012 08/14/2012 08/24/2012
0.10 11/16/2011 11/09/2011 11/18/2011 11/30/2011
0.15 05/27/2011 05/26/2011 06/01/2011 06/16/2011
0.65 12/14/2010 12/01/2010 12/16/2010 12/30/2010
0.25 09/13/2010 09/08/2010 09/15/2010 09/30/2010
0.10 05/27/2010 05/11/2010 06/01/2010 06/16/2010
1.00 12/08/2009 11/24/2009 12/10/2009 12/24/2009
0.25 08/21/2009 08/17/2009 08/25/2009 09/08/2009
0.10 06/11/2009 11/30/-0001 06/15/2009 11/30/-0001
0.10 05/27/2009 05/12/2009 05/29/2009 06/15/2009
1.00 12/10/2008 12/01/2008 12/12/2008 12/30/2008
0.25 10/31/2008 10/15/2008 11/04/2008 11/26/2008
0.25 07/24/2008 07/14/2008 07/28/2008 08/27/2008
0.12 04/28/1998 11/30/-0001 11/30/-0001 11/30/-0001
0.50 04/28/1997 03/26/1997 04/30/1997 05/30/1997